Amylin Pharmaceuticals Announces Time Change to Previously Announced Presentation at the Morgan Stanley Global Healthcare Unplug
May 01 2008 - 12:30AM
PR Newswire (US)
SAN DIEGO, April 30 /PRNewswire-FirstCall/ -- Amylin
Pharmaceuticals, Inc. (NASDAQ:AMLN) today announced it has
re-scheduled its presentation time at the Morgan Stanley Global
Healthcare Unplugged Conference in Key Biscayne, FL to Thursday,
May 1, 2008 at 3:00 p.m. ET / 12:00 p.m. PT. Previously, the
presentation had been scheduled for 9:20 a.m. ET / 6:20 a.m. PT.
Daniel M. Bradbury, President and Chief Executive Officer of Amylin
Pharmaceuticals, will be providing a corporate overview. The live
presentation and breakout session will be webcast, and a recording
will be made available following the event. The webcast and
recording will be accessible through Amylin's corporate website,
located at http://www.amylin.com/. To access the live webcast,
please log on to Amylin's site approximately fifteen minutes prior
to the presentation to register and download any necessary audio
software. About Amylin Pharmaceuticals Amylin Pharmaceuticals is a
biopharmaceutical company committed to improving lives through the
discovery, development and commercialization of innovative
medicines. Amylin has developed and gained approval for two
first-in-class medicines for diabetes, SYMLIN(R) (pramlintide
acetate) injection and BYETTA(R) (exenatide) injection. Amylin's
research and development activities leverage the company's
expertise in metabolism to develop potential therapies to treat
diabetes and obesity. Amylin is headquartered in San Diego,
California with over 1,900 employees nationwide. Further
information on Amylin Pharmaceuticals is available at
http://www.amylin.com/. DATASOURCE: Amylin Pharmaceuticals, Inc.
CONTACT: Michael York, Senior Director, Investor Relations of
Amylin Pharmaceuticals, Inc., +1-858-552-2200, ext. 8602 Web site:
http://www.amylin.com/
Copyright
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024